According to Reuters.com, "Pfizer Inc said on Monday it would acquire Array Biopharma Inc for $10.64 billion in cash, giving it access to the target’s approved drugs for skin cancer and the targeted cancer medicines in its pipeline." Last year, Arrays's oral combination treatment was approved by the Food and Drug Administration for patients with the deadliest form of skin cancer.

http://feeds.reuters.com/~r/reuters/topNews/~3/NF0GcmDM44U/pfizer-to-buy...

Advertisement
EMS.com: Free Shipping on The North Face, UGG, Patagonia, Merrell, Five Fingers, and Garmin!

More videos

Sky News 19 Jul 2019 13:00 CEST

Special report: One Giant Leap